Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Protonix

Protonix Proton Pump Inhibitor Fractures, Bone Fractures, Bone Breaks, Hip Fractures, Wrist Fractures, Spine Fractures

Facebook Twitter Stumble AddThis Social Bookmark Button Pin It Email to Friend Print Page

Protonix Side Effects Hip, Wrist, Spine Fractures Lawsuit

Protonix | Lawsuits, Lawyers | Side Effects: Bone Fractures, Bone Breaks, Hip Fractures, Wrist Fractures, Spine Fractures

Our proton pump inhibitor lawyers are investigating injuries linked to these heartburn treatments. Prescription versions of the drugs include Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, and Aciphex. Over-the-counter brands include Prilosec OTC, Zegerid OTC and Prevacid 24HR. Proton pump inhibitors are extremely popular, with doctors writing roughly 113.4 million prescriptions for the drugs every year.

Prescription proton pump inhibitors like Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, and Aciphex are used to treat conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus. Prilosec OTC, Zegerid OTC and Prevacid 24HR are approved for the treatment of frequent heartburn.

In recent years, proton pump inhibitors have been linked to a number of serious side effects, including:

  • Increased risk of a hip, wrist or spine fractures
  • Interference with the blood-clotting properties of Plavix
  • Increased risk of serious cardiac event following a heart attack

If you or a loved one suffered one of these proton pump inhibitor side effects, you may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. Our proton pump inhibitor lawyers are currently offering free case evaluations to victims of these injuries. We urge you to contact us today to protect your legal rights.

Proton Pump Inhibitors and Fractures

Proton pump inhibitors work by reducing acid in the stomach. Over time, this may inhibit the body's ability to absorb calcium, which can lead to osteoporosis. In May 2010, the US Food & Drug Administration (FDA) announced that the safety labeling for both prescription and over-the-counter proton pump inhibitors would be updated to include information on an increased risk of certain fractures associated with their use.

The label change was based on the agency’s review of several epidemiological studies that reported an increased risk of fractures of the hip, wrist, and spine with proton pump inhibitor use. Some studies found that those at greatest risk for these fractures received high doses of proton pump inhibitors or used them for one year or more. The majority of the studies evaluated individuals 50 years of age or older and the increased risk of fracture primarily was observed in this age group.

The FDA advised that healthcare professionals and users of proton pump inhibitors be aware of the possible increased risk of fractures of the hip, wrist, and spine, and weigh the known benefits against the potential risks when deciding to use these drugs.

Proton Pump Inhibitors and Plavix

In November 2009, the FDA issued a public health alert to warn Plavix users that Nexium and Prilosec could reduce that drug's anti-clotting effects. Prilosec inhibits the drug metabolizing enzyme (CYP2C19) which is responsible for the conversion of Plavix into its active form (active metabolite), the FDA said. As a result, patients taking both drugs could face a higher risk of heart attack or stroke.

The FDA issued the health alert after studies compared the amount of Plavix’s active metabolite in the blood and its effect on platelets (anti-clotting effect) in people who took Plavix and Prilosec versus those who took Plavix alone. A reduction in active metabolite levels of about 45 percent was found in people who received Plavix with Prilosec compared to those taking Plavix alone. The effect of Plavix on platelets was reduced by as much as 47 percent in people receiving Plavix and Prilosec together. These reductions were seen whether the drugs were given at the same time or 12 hours apart, the agency said.

Nexium also inhibits CYP2C19 and should also be avoided in combination with Plavix. The FDA advised people taking Plavix to consult their healthcare provider if they were currently taking or were considering taking Prilosec, Prilosec OTC or Nexium.

Proton pump inhibitors are often prescribed to Plavix patients to minimize gastric effects such as nausea and heartburn. According to the FDA, the level of CYP2C19 inhibition among other proton pump inhibitors varies, so it is unknown to what extent other proton pump inhibitors may interfere with Plavix.

Proton Pump Inhibitors After a Heart Attack

In September 2010, a study published of over 56,000 Danish patients discharged after a heart attack found that those who had at least one prescription for a proton pump inhibitor had a 29 percent increased risk of cardiovascular death or re-hospitalization for a heart attack or stroke in the 30 days after discharge compared with those who did not receive such a drug. The study was published in the Annals of Internal Medicine.

The study also cast doubt on concerns that proton pump inhibitors inhibit the effectiveness of Plavix.  Among the patients in this study, the risk for additional cardiac events was exactly the same for those prescribed a proton pump inhibitor and Plavix, compared to those not prescribed a proton pump inhibitor. The researchers concluded that the increased risk of a heart attack, stroke or death is associated with proton pump inhibitors, and not the combination of Plavix and a proton pump inhibitor.

Legal Help for Victims of Proton Pump Inhibitor Side Effects

If you or a loved one were treated with proton pump inhibitors and suffered any of the above injuries, you may have valuable legal rights. Please fill out our online form, or call 1-800-YOURLAWYER (1-800-968-7529) to discuss your case with one of our proton pump inhibitor lawyers today.


Protonix Linked to Hip Fractures

Protonix (generic: pantoprazole) is just one of a few antacid medications that  are called proton pump inhibitors. Other common proton pump inhibitor drugs include Aciphex, Nexium, Prevacid and Prilosec. Protonix is manufactured by Wyeth-Ayerst Laboratories and gained FDA approval in 2000.

Proton Pump Inhibitors Linked to Hip Fractures

On December 26, 2006, a report was released that showed the correlation between people taking powerful antacid drugs called proton pump inhibitors and the increased risk of hip fractures.  The report was based on a University of Pennsylvania study that showed a class of antacid drugs called proton pump inhibitors could increase the risk of hip fractures as much as 260 percent. Proton pump inhibitors are usually prescribed for gastroesophageal reflux disease (GERD), and are.among the most widely used drugs in the United States. Popular drugs in the class include: Aciphex, Nexium, Prevacid, Prilosec and Protonix. which are often prescribed for stomach conditions.

The University of Pennslyvania report can be found in the Dec. 27, 2006 issue of the Journal of the American Medical Association (JAMA).

If you take acid-suppression medications on a chronic basis and you are 50 or older, your hip fracture risk is even higher than usual," said study author Dr.Yu-Xiao Yang, an assistant professor of medicine and epidemiology. "In addition, if you are one of the few patients who requires high doses, then your risk is even higher," Yang added.

Study Results

In the study, a team lead by study author Dr.Yu-Xiao Yang collected statistics on 13,556 people with hip fractures and 135,386 healthy people, all aged 50 or older. The researchers discovered that taking a proton pump inhibitor for more than one year increased the threat of hip fracture by 44%, compared with people not taking these medications. Additionally, the risk was 2.6 times higher among people who took high doses over a long period. The risk of hip fracture increased with both the dosage and the duration of proton pump inhibitor therapy, Yang's team found.

Yang said he feels these drugs are prescribed too often. "Not everybody is on this medicine for good reasons," he said. "Proton pump inhibitors have been on the market for 15 years, and the general feeling is that they are safe to be taken on a chronic basis. So, they are given often without having a clear indication or without making sure the patient is benefiting from the medication." Moreover, Yang thinks that both men and women taking prescription proton pump inhibitors should also take a calcium supplement to insure that they maintain their bone mass and lower their risk of hip fracture.

Dr. Lawrence Brandt, chief of the Division of Gastroenterology at Montefiore Medical Center, in New York City, said "Proton pump inhibitors are probably one of the most abused classes of drugs in the world. So, there are a lot of people on this medication who shouldn't be on this medication." While Acphex, Nexium Prevacid and Protonix all require a prescription, Prilosec is now sold over the counter which increases the potential for overuse.

Proton Pump Inhibitors and Hypomagnesemia

The long-term use of proton pump inhibitors has been associated with hypomagnesemia, a condition caused by low levels of magnesium in the blood. In March 2011, the U.S. Food & Drug Administration (FDA) mandated that the makers of prescription proton pump inhibitors include information about the potential risk of low magnesium in the WARNINGS AND PRECAUTIONS sections of the labels for all prescription proton pump inhibitors. Proton pump inhibitors subjected to the new warnings included: Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, AcipHex, and Vimovo.

Low serum magnesium levels can result in serious adverse events including:
  • Muscle spasm
  • Arrhythmias (irregular heartbeat)
  • Seizures

According to the FDA, hypomagnesemia has been reported in adult patients taking proton pump inhibitors for at least three months, but most cases occurred after a year of treatment. Approximately one-quarter of these cases required discontinuation of proton pump inhibitor treatment in addition to magnesium supplementation. It is not understood why long-term proton pump inhibitor treatment sometimes results in hypomagnesemia. The FDA has recommended that healthcare providers consider obtaining serum magnesium levels before their patients begin treatment with prescription proto pump inhibitors. The agency said they should also consider periodic testing if patients are also being treated with medications such as digoxin, diuretics or drugs that may cause hypomagnesemia. In digoxin patients especially, low magnesium can increase the likelihood of serious side effects.

Legal help for Protonix users

If you or a loved one suffered a fractured hip as a result of using a Proton Pump Inhibitor, contact Parker & Waichman, LLP for a free case evaluation. Call 1-800-YOURLAWYER (1-800-968-7529) or fill out the short form to the right of this page.

Tags:  
ProtonixRSS Feed

Study Finds PPIs Significantly Increase C. Diff Risk

Jul 11, 2012 | Parker Waichman LLP
Proton pump inhibitor drugs (PPIs) significantly increase the risk of a person developing Clostridium difficile-associated diarrhea (CDAD), according to a new study.Researchers at Harper University Hospital in Michigan and University of Utah School of Medicine discovered that people taking PPI drugs like Aciphex, Nexium, Omeprazole, Prevacid, Prilosec, and Protonix, are two-thirds more likely to develop CDAD than those not taking any of these drugs. PPI drugs are among the most commonly...

FDA Warns PPIs May Cause Severe Diarrheal Infection

Feb 9, 2012 | Parker Waichman LLP
Patients who take proton pump inhibitors (PPIs) may be at a higher risk of developing a serious condition called Clostridium difficile–associated diarrhea (CDAD).  The danger prompted the U.S. Food & Drug Administration (FDA) to issue a Drug Safety Communication yesterday, and announce that it was working with the makers of PPIs to add information about their association with CDAD to the drug's labels.CDAD is a type of diarrhea that does not improved.  It is caused by...

Plavix, Proton Pump Inhibitor Warnings Revised in Canada

Sep 23, 2011 | Parker Waichman LLP
Health Canada is revising the label for Plavix in that country to reflect new information about the concurrent use of the blood thinner and other drugs called proton pump inhibitors (PPIs).   Many Plavix users take PPIs to counteract the ulcers and heartburn that can accompany use of the blood thinner.In 2009, Health Canada updated the labels for ALL PPIs to recommend they not be used with Plavix, after some research indicated that the drugs could reduce the efficacy of Plavix. ...

Heartburn Drugs May Up Risk of C. Difficile by 80 Percent

Nov 8, 2010 | Parker Waichman LLP
A new study suggests that taking proton pump inhibitors could increase the risk of contracting Clostridium difficile–associated diarrhea (CDAD) by as much as 80 percent. C. difficile represents an escalating threat to public health, and CDAD cost the US an estimated $3 billion in 2005. Proton pump inhibitors, available by prescription and over-the-counter (OTC), work by reducing the amount of acid in the stomach, and are approved to treat conditions such as gastroesophageal reflux...

Protonix Ups Pneumonia Risks

Sep 16, 2009 | Parker Waichman LLP
Protonix, the popular stomach-acid medication, has been linked to increased pneumonia risks. Science Daily explained that Protonix, when used to prevent stress ulcers in critically ill patients on ventilation, presents a three-fold increase for pneumonia, citing Wake Forest University School of Medicine researchScience Daily explained that in critically ill patients, hospital-acquired pneumonia is the number one cause of infection-related deaths and increases hospital stay time by about...

More Protonix News

Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo Protected by Copyscape Web Copyright Protection Software php-5 VendorsBay Inc